Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$27.83 USD
+0.10 (0.34%)
Updated Apr 23, 2024 03:14 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Royalty Pharma (RPRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$45.00 | $60.00 | $37.00 | 61.75% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Royalty Pharma comes to $45.00. The forecasts range from a low of $37.00 to a high of $60.00. The average price target represents an increase of 61.75% from the last closing price of $27.82.
Analyst Price Targets (7 )
Broker Rating
Royalty Pharma currently has an average brokerage recommendation (ABR) of 1.21 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.21 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, five are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 71.43% and 28.57% of all recommendations. A month ago, Strong Buy made up 71.43%, while Buy represented 28.57%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.21 |
ABR (Last week) | 1.21 |
# of Recs in ABR | 7 |
Average Target Price | $45.00 |
LT Growth Rate | NA |
Industry | Financial - Miscellaneous Services |
Industry Rank by ABR | 94 of 252 |
Current Quarter EPS Est: | 0.96 |